Till startsida
University of Gothenburg
To content Read more about how we use cookies on gu.se

Ongoing studies


  • A clinical trial (phase II study) with IGF-I/IGFBP-3 administration www.clinicaltrials.gov NCT 01096784
  • A clinical trial (Donna Mega) to investigate the impact of DHA/EPA on retinophaty, visual and neural development EUDRA-CT no 2008-000046-31
  • A clinical trial (Mega Donna Mega) to investigate the impact of AA/DHA on retinopathy, visual and neural development.
  • Further validation of WINROP® (national & international)
  • Ophthalmologic follow-up studies of infants with perinatal adverse history
  • Investigating the impact of postnatal serum IGF-I levels on preterm morbidity and postnatal growth
  • Effect of blood components importance for neuro- and angiogenesis in premature infants
  • Metabolic and Pharmakoninetic analysis of intravenous insulin administration to very preterm infants
  • Development of a digiatal e-health solution for ROP screening and diagnosis


  • Investigating the impact of chronic inflammation on ROP development in an experimental neonatal animal model
  • A proteomic and luminex approach for identification of biomarkers in amnion, cord blood and serum that may predict an increased risk for ROP


Page Manager: Carola Pfeiffer Mosesson|Last update: 6/21/2018

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?

Denna text är utskriven från följande webbsida:
Utskriftsdatum: 2020-08-14